Aker Biomarine ASA
OSE:AKBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Powell Industries Inc
NASDAQ:POWL
|
US |
Aker Biomarine ASA
Total Liabilities & Equity
Aker Biomarine ASA
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Aker Biomarine ASA
OSE:AKBM
|
Total Liabilities & Equity
$384.9m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Orkla ASA
OSE:ORK
|
Total Liabilities & Equity
kr88.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Leroy Seafood Group ASA
OSE:LSG
|
Total Liabilities & Equity
kr40.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
|
SalMar ASA
OSE:SALM
|
Total Liabilities & Equity
kr57.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
21%
|
CAGR 10-Years
18%
|
|
|
Austevoll Seafood ASA
OSE:AUSS
|
Total Liabilities & Equity
kr53.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
|
Mowi ASA
OSE:MOWI
|
Total Liabilities & Equity
€10.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
|
Aker Biomarine ASA
Glance View
Aker BioMarine AS operates as a biotech innovator and Antarctic krill-harvesting company which develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
See Also
What is Aker Biomarine ASA's Total Liabilities & Equity?
Total Liabilities & Equity
384.9m
USD
Based on the financial report for Dec 31, 2025, Aker Biomarine ASA's Total Liabilities & Equity amounts to 384.9m USD.
What is Aker Biomarine ASA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-11%
Over the last year, the Total Liabilities & Equity growth was 1%. The average annual Total Liabilities & Equity growth rates for Aker Biomarine ASA have been -22% over the past three years , -11% over the past five years .
